Use of the indicators of the proliferative... (1986 study) Skip to main content
Study Med Radiol (Mosk) 1986

Use of the indicators of the proliferative activity of tumors of the oropharyngeal area as qualitative prognostic criteria of the radiotherapy

Poliakov P, Karakulov R, Pelevina I, Zazovskiĭ L, Dar'ialova S, Med Radiol (Mosk), 1986

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers took tumor biopsy samples from patients with oropharyngeal cancer and measured how fast the tumor cells were dividing before and during radiotherapy.

What They Found

In patients with oropharyngeal cancer, this study found that the drop in tumor cell growth markers (labeling index and growth fraction) during radiotherapy was a more important sign of tumor response to radiation than their starting values. A fall to 0 or a sharp decrease in these values was a favourable sign and pointed to high tumor sensitivity to radiation, which allowed radiotherapy to continue on the radical program. A tumor was considered radioresistant if these values rose by the end of the interval in the middle of a split course. The authors reported that patients with resectable tumors should finish treatment with an operation. For unresectable tumors, treatment should be followed by combined radiotherapy with an increased dose of interstitial gamma-therapy. The abstract gives no sample size or p-values.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy. It describes how changes in tumor cell growth markers during radiotherapy were used to judge how a tumor was responding and to guide the next treatment steps in oropharyngeal cancer. It gives no information about HBOT.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract does not report how many patients were studied, gives no statistical tests, and does not describe a comparison group, so the strength of these prognostic and treatment conclusions cannot be judged from it.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Radiation Injury
Source Pubmed
PubMed ID 3796252
Year Published 1986
Journal Med Radiol (Mosk)
MeSH Terms Brachytherapy; Carcinoma, Squamous Cell; Humans; Hyperbaric Oxygenation; Metronidazole; Mouth Neoplasms; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Prognosis; Radiation Tolerance; Radiotherapy Dosage; Tongue Neoplasms

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology